Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
DDmuqX4Jf75QvA9K
